Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Arketamine - Jiangsu Hengrui Medicine

Drug Profile

Arketamine - Jiangsu Hengrui Medicine

Alternative Names: HR 071603; Hydrochloric Acid (R) - Ketamine Nasal Spray - Jiangsu Hengrui Medicine; Ketamine Nasal Spray - Jiangsu Hengrui Medicine; R-ketamine - Jiangsu Hengrui Medicine

Latest Information Update: 17 Oct 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Jiangsu Hengrui Medicine Co.
  • Class Analgesics; Antidepressants; Behavioural disorder therapies; Chlorobenzenes; Cyclohexanones; Small molecules
  • Mechanism of Action AMPA receptor agonists; NMDA receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Depressive disorders

Most Recent Events

  • 17 Oct 2019 Chemical structure information added
  • 01 Oct 2019 Preclinical trials in Depressive disorders in China (Intranasal)
  • 01 Oct 2019 Jiangsu Hengrui Medicine plans a phase I trial for Depressive disorders (In volunteers) (Intranasal, Spray) in October 2019 (NCT04108234)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top